Mr. Thiago Jordão S Lemos | Nanobiotechnology Awards | NanoHealth Innovator Prize

Mr. Thiago Jordão S Lemos | Nanobiotechnology Awards | NanoHealth Innovator Prize

Mr. Thiago Jordão S Lemos , Instituto Butantan , Brazil

Thiago Jordão da Silva Lemos is a biomedical researcher currently affiliated with the Butantan Institute in São Paulo, Brazil. He earned his degree in Biomedicine from Universidade Paulista (UNIP) and has extensive experience in research and development, particularly in immunology and animal health. He completed a postgraduate program at the Butantan Institute, focusing on microbiology, where he investigated the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. Lemos has also held roles as a nursing technician and assistant and participated in a short-term internship at the Biophysics Institute of the Federal University of Rio de Janeiro (UFRJ). His research interests include vaccine development and infectious diseases, and he is actively involved in evaluating immune responses to pathogens in order to develop effective vaccines.

Professional Profile:

Orcid

 🎓Education:

Thiago Jordão da Silva Lemos earned his degree in Biomedicine from Universidade Paulista (UNIP), Brazil, with a thesis titled “Frequency of Bovine Viral Diarrhea in the State of São Paulo,” under the guidance of Ediviges Maristela Pituco. He further pursued postgraduate studies at the Butantan Institute, focusing on microbiology, where he researched the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. Additionally, Lemos completed a short-term internship at the Biophysics Institute of the Federal University of Rio de Janeiro (UFRJ)

 🏢Work Experience:

Lemos is currently affiliated with the Butantan Institute in São Paulo, Brazil, where he works on evaluating immune responses to pathogens to develop effective vaccines. He has held roles as a nursing technician and assistant and has been a member of a research team investigating the immune response induced by an oral vaccine against E. coli serogroups O26 and O111. His professional experience encompasses research and development in immunology and animal health, with a focus on vaccine development and infectious diseases.

Publication Top Notes:

  • O26 Polysaccharides as Key Players in Enteropathogenic E. coli Immune Evasion and Vaccine Development
    • Journal: International Journal of Molecular Sciences
    • Publication Date: 2024-03-01
  • Characterization of O26 Enteropathogenic E. coli and Its Implication for Vaccine Development
    • Publication Date: 2023-12-19
  • The potential of Loxosceles gaucho spider venom to regulate Pseudomonas aeruginosa mechanisms of virulence
    • Journal: Toxicon
    • Publication Date: 2018
  • Potential influence of bacterial biofilm formation on scalp folliculitis therapy

 

 

 

 

Assist. Prof. Dr. Rana Youness | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Rana Youness | Nanobiotechnology Awards | Best Researcher Award

Assist. Prof. Dr. Rana Youness , German International University, Egypt

Rana Ahmed Youness, PhD, is an accomplished molecular biologist and assistant professor, currently serving as Head of Research and Industrial Link Committee at the German International University (GIU), Cairo. With expertise in pharmaceutical biology, her research focuses on the role of hydrogen sulphide in breast cancer signaling pathways. Dr. Youness has held various academic and research positions, including Assistant Professor at GIU and Module Lead at the University of Hertfordshire-Egypt. She has received numerous awards, including the L’OREAL-UNESCO For Women In Science Award and grants from institutions like the Swiss National Science Foundation. Dr. Youness is dedicated to advancing knowledge in molecular genetics and biochemistry, with a particular interest in oncology and immunotherapy.

Professional Profile:

Scopus

Orcid

🎓 Education:

Dr. Rana Ahmed Youness holds a distinguished academic background, having earned her Ph.D. in Pharmaceutical Biology, M.Sc. in Pharmaceutical Biology, and B.Sc. in Pharmacy and Biotechnology, all from the esteemed German University in Cairo. Throughout her academic journey, Dr. Youness has demonstrated a strong commitment to excellence and scholarly achievement. Her doctoral research focused on shedding light on the role of Hydrogen Sulphide and its associated signaling pathways in Breast Cancer, a topic of critical importance in the field of pharmaceutical biology. Building upon her master’s thesis, which delved into epigenetic modulation of immune effector cells to combat liver cancer, Dr. Youness has consistently exhibited a passion for advancing knowledge and addressing pressing issues in the field of biomedical science. Her educational qualifications reflect a solid foundation in pharmaceutical biology and biotechnology, providing her with the expertise needed to contribute meaningfully to research and academia.

👩‍🔬 Professional Experience:

Dr. Rana Ahmed Youness currently serves as the Head of the Research and Industrial Link Committee at the German International University, where she plays a pivotal role in fostering collaborations between academia and industry to drive innovation and advance research endeavors. Concurrently, she holds the position of Assistant Professor of Molecular Genetics and Biochemistry, leveraging her expertise to educate and inspire the next generation of scientists. Dr. Youness is also recognized as the Founder of the Pharmacognosy and Medicinal Plants Module, a testament to her dedication to curriculum development and the integration of cutting-edge research topics into academic programs.

🏆 Prizes, Grants, and Scholarships:

Dr. Rana Ahmed Youness has been recognized with prestigious awards and honors for her outstanding contributions to the field of science and medicine. Notably, she was honored with the L’OREAL-UNESCO For Women In Science Award, a testament to her exceptional achievements and leadership in scientific research. In addition, Dr. Youness received the State Encouragement Award in Medicinal Sciences, acknowledging her significant contributions to advancing knowledge and innovation in the field of medicine. Her merit awards from organizations such as ESMO (European Society of Medical Oncology) further underscore her dedication and impact in the scientific community, highlighting her commitment to excellence and the pursuit of groundbreaking discoveries.

Publication Top Notes:

  1. Rashid, G., Khan, N.A., Elsori, D., … Babker, A.M., Hafez, W. (2024). “miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery.” Archives of Gynecology and Obstetrics, 309(5), pp. 1707–1723. [Cited by 2 articles]
  2. Rashwan, H.H., Taher, A.M., Hassan, H.A., … Assal, R.A., Youness, R.A. (2024). “Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies.” Pathology Research and Practice, 256, 155223. [Cited by 1 article]
  3. Dawoud, A., Elmasri, R.A., Mohamed, A.H., … Rostom, M.M., Youness, R.A. (2024). “Involvement of CircRNAs in regulating The ‘New Generation of Cancer Hallmarks’: A Special Depiction on Hepatocellular Carcinoma.” Critical Reviews in Oncology/Hematology, 196, 104312. [Cited by 1 article]
  4. Fahmy, S.A., Elghanam, R., Rashid, G., Youness, R.A., Sedky, N.K. (2024). “Emerging tendencies for the nano-delivery of gambogic acid: a promising approach in oncotherapy.” RSC Advances, 14(7), pp. 4666–4691. [Cited by 0 articles]
  5. Youness, R.A., Habashy, D.A., Khater, N., … Abdel-Kader, R.M., Gad, M.Z. (2024). “Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review.” Non-coding RNA, 10(1), 7. [Cited by 4 articles]